Clinical Trial Update: Efficacy and Safety of Hemoperfusion With Polymyxin B in Septic Shock Associated With Severe Endotoxemia in Cardiac Surgery Patients (РМХ vs SS) [NA]

View source ↗

Summary

A recruiting clinical trial evaluating hemoperfusion with Polymyxin B for septic shock associated with severe endotoxemia in cardiac surgery patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endotoxemia
• Multiple Organ Dysfunction Syndrome
• Sepsis
• Septic Shock

Drugs mentioned

• Polymyxin B hemoperfusion (Polymyxin B)

Snippet

Sponsor: Petrovsky National Research Centre of Surgery | Conditions: Multiple Organ Dysfunction With Severe Endotoxemia | NA | Status: RECRUITING